Literature DB >> 25643229

Temporomandibular disorders, headaches and chronic pain.

Joanna M Zakrzewska1.   

Abstract

Temporomandibular disorders (TMDs) are a major cause of non-dental orofacial pain with a suggested prevalence of 3% to 5% in the general population. TMDs present as unilateral or bilateral pain centered round the pre-auricular area and can be associated with clicking and limitation in jaw movements. It is important to ascertain if there are other comorbid factors such as headaches, widespread chronic pain and mood changes. A biopsychosocial approach is crucial with a careful explanation and self-care techniques encouraged.

Entities:  

Keywords:  TMDs; behavioral techniques; exercise; headaches; mood; pharmacotherapy; temporomandibular disorders

Mesh:

Year:  2015        PMID: 25643229     DOI: 10.3109/15360288.2014.1003678

Source DB:  PubMed          Journal:  J Pain Palliat Care Pharmacother        ISSN: 1536-0288


  4 in total

1.  Somatosensory profiles of patients with chronic myogenic temporomandibular disorders in relation to their painDETECT score.

Authors:  C Welte-Jzyk; D B Pfau; A Hartmann; M Daubländer
Journal:  BMC Oral Health       Date:  2018-08-09       Impact factor: 2.757

Review 2.  Biomarkers for Temporomandibular Disorders: Current Status and Future Directions.

Authors:  Abdalwhab Zwiri; Mohammad A I Al-Hatamleh; Wan Muhamad Amir W Ahmad; Jawaad Ahmed Asif; Suan Phaik Khoo; Adam Husein; Zuryati Ab-Ghani; Nur Karyatee Kassim
Journal:  Diagnostics (Basel)       Date:  2020-05-15

Review 3.  Management of pain in patients with temporomandibular disorder (TMD): challenges and solutions.

Authors:  Alfonso Gil-Martínez; Alba Paris-Alemany; Ibai López-de-Uralde-Villanueva; Roy La Touche
Journal:  J Pain Res       Date:  2018-03-16       Impact factor: 3.133

4.  Ultrasound is Effective to Treat Temporomandibular Joint Disorder.

Authors:  Shuang Ba; Pin Zhou; Ming Yu
Journal:  J Pain Res       Date:  2021-06-10       Impact factor: 3.133

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.